MedTrace Logo

Evaluation of a Novel Product for the Removal of Impacted Human Cerumen (Earwax)

NCT02829294 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2019-10-04

Study results available
· View outcomes & findings →

Summary

This is a prospective, open-labeled clinical trial. Subjects that qualify for enrollment and provide informed consent will be treated with a novel topical cerumen (earwax) removal product. The primary goal of this pilot study is to gain an understanding of the safety and efficacy of this novel product.

Conditions

  • Cerumen Impaction of Both Ears

Interventions

DEVICE

E002 - cerumen removal aid

topical treatment

Sponsors & Collaborators

  • Dr. Joseph Griffin

    lead INDUSTRY

Principal Investigators

  • Joe Griffin, PhD · Eosera Inc

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2016-05-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02829294 on ClinicalTrials.gov